Pfizer is a major partner of WHO for eliminating trachoma, establishing the International Trachoma Initiative (ITI) in 1998 together with the Edna McConnell Clark Foundation. Pfizer will donate azithromycin free of charge until 2020. Additionally, Pfizer undertakes comprehensive measures for research, treatment, prevention, and public awareness.
< Appearance of a trachoma patient > CDC
Blinding trachoma is a type of conjunctivitis caused by Chlamydia trachomatis, a bacterium that is transmitted to healthy eyes by a discharge from an infected eye. If repeated, it can lead to blindness, and that is why this disease is called blinding trachoma. It is epidemic mainly in developing countries and, according to data released by the World Health Organization (WHO), tracoma is responsible for the blindness or visual impairment of about 1.9 million people.
Causes of Infection
Chlamydia trachomatis (bacterium)
< Chlamydia trachomatis >
< Host fly (in general, not limited to this species) >
Dr. Gary Alpert
This disease occurs when Chlamydia trachomatis is transmitted to eyes via hands, clothes, and towels used by those infected or via flies that land on the eyes or noses of the infected.
Since the agent of this disease is easily transmitted via human contact, widespread infections are common. Children who touch their eyes often or are too young to wash their faces and their mothers are particularly susceptible to infection. Infection is more likely to come from areas where water is in short supply or that are unhygienic and infested with flies.
Trachoma’s symptoms are divided into two stages:
< Appearance of a trachoma patient > CDC
Lumps like millet seed appear on the palpebral conjunctiva of upper eyelids. When these lumps grow and burst, scar (white lines) and star-shaped tissues appear.
Palpebral conjunctiva of the upper eyelid spreads and becomes red, irregular, and thick. After repeated infections over a long period the eyelid rides up the eyeball, constantly injuring the cornea with eyelashes (inturned eyelashes). Accompanied by pain, this symptom leads to corneal clouding, blurred vision, and, eventually, blindness.
After repeated infections from the first infection in childhood, people become blind in their 30s or 40s. Women in middle age and older who have frequent contact with children are also susceptible to infection.
Diagnosis and Treatment
Treatment include drugs and/or surgical operation
Drug cures include azithromycin and tetracycline eye ointment.
Since trachoma is highly infectious, antibiotic drugs such as azithromycin are effective. In light cases, a few doses of azithromycin are believed to be enough. For infants under six months, a combination of a small dose of tetracycline eye ointment and azithromycin is used.
Tetracycline eye ointment should be applied directly to the eye twice a day for six weeks. Since it is painful, patients may not want it to be continually applied. Additionally, although tetracycline eye ointment is effective in controlling inflammation, it does not prevent re-infection. Therefore, the trend is shifting to using azithromycin.
Eyelids that have risen up the eyeball can be easily treated with a simple surgical operation.
The most fundamental and important preventive measure is to wash the hands and face with clean water. Across the community, hygiene is essential including clean toilets, eradicating flies, safe, hygienic water and food, as well as separating people and animals.
Regions at High Risk of Infection (major endemic areas)
Ninety eight percent (98%) of trachoma infections are found in developing countries and the infection rate is particularly high in areas with poor hygiene, poverty, as well as shortages of water and medical services. According to 2016 data from the WHO, infections were reported in 42 countries in Africa, Central and South America, Asia, Australia and the Middle East. In the areas with particularly high infection rates, it is estimated that some 60 to 90% of pre-school children are infected.
Estimated Number of Infected People
Also according to 2016 data released by WHO, tracoma is responsible for the blindness or visual impairment of about 1.9 million people. Infection rates are particularly high among children under five as well as adult females who take care of infected children.
Estimated Number of Deaths
There have been no deaths attributed to trachoma as the direct cause.
Initiatives by Pharmaceutical Companies and NGOs
International activities for the treatment and elimination of trachoma are based on WHO’s (World Health Organization) “SAFE” strategy. SAFE strategy has four components:
- S for Surgery: Treatment of trichiasis (the last stage of trachoma where eyelashes roll up inside the eyelid and scratch the eyeball, damaging the cornea and causing blindness) with a surgical operation
- A for Antibiotics: Treatment of those infected with antibiotics (azithromycin)
- F for Facial cleanliness: Improved hygiene and reduced risk of infection from facial cleanliness
- E for Environment: Better access to public sanitation and clean water through an improved environment
WHO has been eliminating blindness caused by trachoma since 1996. This is a part of WHO’s Vision 2020 initiative (measures against major blindness diseases), setting out the goal of eliminating trachoma by 2020 based on the SAFE strategy (above). This program is formally called Global Elimination of Trachoma by the Year 2020 (GET 2020). A large trachoma eradication program using azithromycin was conducted in Morocco as a part of the SAFE strategy. WHO and its partners support the implementation of the SAFE strategy and collaboration on the complete elimination of trachoma.
Lions Clubs International Foundation has a project to eliminate blindness called SightFirst. As a part of this project, Lions Clubs International donated azithromycin to 10 million Ethiopians in collaboration with Lions Clubs Ethiopia, the Ethiopian government, Pfizer, and The Carter Center (founded by former US President Jimmy Carter).
At the time of the London Declaration in 2012, Lions Clubs International Foundation also announced that it would provide $6.9 million to the Chinese government’s program to eliminate trachoma by 2017.
WHO- Neglected Tropical Diseases, accessed March 19, 2014,
CDC- Neglected Tropical Diseases, accessed March 19, 2014,